Zhi Wang

16PUBLICATIONS
84CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 14, 2025
T lymphocyte-specific deletion of SHP1 and SHP2 promotes activation-induced cell death of CD4<sup>+</sup> T cells and impairs antitumor response.

Connor J R Foster, Jasper Du, Oscar Pundel

|Jan 13, 2025
T Lymphocyte-Specific Deletion of SHP1 and SHP2 Promotes Activation-Induced Cell Death of CD4+ T Cells and Impairs Antitumor Response.

Connor J R Foster, Jasper Du, Oscar Pundel

|Mar 14, 2024
Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and function.

John L Silberstein, Jasper Du, Kun-Wei Chan

|Mar 08, 2024
Transmembrane domain-driven PD-1 dimers mediate T cell inhibition.

Elliot A Philips, Jia Liu, Audun Kvalvaag

|Dec 28, 2022
CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary.

Ignacio Melero, Miguel F Sanmamed, Javier Glez-Vaz

Pageof 3